Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S-(2-{[N-(2-hydroxy-4-{[hydroxy(oxido)phosphino]oxy}-3,3-dimethylbutanoyl)-beta-alanyl]amino}ethyl) heptanethioate
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
S-(2-{[N-(2-hydroxy-4-{[hydroxy(oxido)phosphino]oxy}-3,3-dimethylbutanoyl)-beta-alanyl]amino}ethyl) heptanethioate is a synthetic organophosphorus compound classified as a small molecule. It is structurally related to the class of beta amino acids and derivatives and contains a phosphinic acid moiety. The compound has not been approved for any medical use and is considered experimental. There are no known clinical trials or therapeutic indications for this molecule. Its mechanism of action has not been characterized in the literature or drug databases as of now. It is primarily referenced in chemical structure databases and research resources as an experimental or structural ligand rather than an active pharmaceutical ingredient.[5][8][7]
- Other names
- [(3R)-3-[(2-{[2-(heptanoylsulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]-3-hydroxy-2,2-dimethylpropoxy]phosphinic acidS-[2-[{N-[(2R)-2-hydroxy-4-{[hydroxy(oxido)phosphoranyl]oxy}-3,3-diméthylbutanoyl]-β-alanyl}amino]éthyle]InChIKey: IPSBILXXAVXCDA-INIZCTEOSA-N
Beyond the preview
Go deeper on S-(2-{[N-(2-hydroxy-4-{[hydroxy(oxido)phosphino]oxy}-3,3-dimethylbutanoyl)-beta-alanyl]amino}ethyl) heptanethioate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on S-(2-{[N-(2-hydroxy-4-{[hydroxy(oxido)phosphino]oxy}-3,3-dimethylbutanoyl)-beta-alanyl]amino}ethyl) heptanethioate.